• Gene therapy improves muscle function for children with Spinal Muscular Atrophy

  • Dec 12 2021
  • Duración: 4 m
  • Podcast

Gene therapy improves muscle function for children with Spinal Muscular Atrophy  Por  arte de portada

Gene therapy improves muscle function for children with Spinal Muscular Atrophy

  • Resumen

  • Children with spinal muscular atrophy(SMA) carry specific gene defects which cause progressive muscle wasting and weakness. The disorder results from a genetic defect that causes a deficiency of the survival motor neuron (SMN) protein in specific nerve cells in the spinal cord. Defective nerve cells are unable to transmit nerve impulses they receive from the brain to the muscles. The result is progressive muscle weakness and a lack of motor development, which also affects the muscles used for breathing. This condition usually results in early death when left untreated. 

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Gene therapy improves muscle function for children with Spinal Muscular Atrophy

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.